You need to be logged in to view this video

Breakthrough Biotech Medicine to Treat the Cause of Death of 65% of all Adults

Released on Tuesday, April 21, 2026•HEALTHCARE

Share
Facebook Twitter LinkedIn SMS

Zhittya Genesis Medicine has developed a medicine to treat diseases caused by a lack of blood flow. During this presentation you will explore how Zhittya is using their FGF-1 to treat heart disease, Parkinson's disease, Type-2 Diabetes, and more.

Daniel Montano

Zhittya Genesis Medicine, Inc., CEO

Dan Montano started at the Los Angeles Stock Exchange in 1968 as a floor broker. Over the next 30 years, he managed thousands of stockbrokers as CEO of several security firls. In 1998, he left investment banking and dedicated himself to advance biotechnology breakthroughs. Presently, he is CEO of Zhittya Genesis Medicine Inc., a bio-pharaceutical company developing drug treatments for heart disease, strokes, Parkison's disease, Alzheimer's, and more.